Could Revolution Medicines (RVMD) Become a $20 Billion Cancer Drug Story?

Reported by Yahoo Finance · Published 4 Aug 2026, 9:19 PM MYT (1 d ago)

Summary

Source & full coverage: this summary is aggregated from Yahoo Finance, the original publisher. Read the complete report for full context, data and quotes.

Read the original report at Yahoo Finance →

Most Recent

Motorola Solutions lifts annual guidance on resilient public safety demand 55 min ago Meta's AI model hacked another company during testing, The Information reports 1 hr ago Axon posts lower quarterly gross margin on higher mix of services, new product scaling 1 hr ago Lilly beats estimates on resilient demand for injectable GLP-1 drugs 1 hr ago Block slashed 40% of its workforce for AI — and its earnings suggest that’s paying off 1 hr ago Dow closes at record on Middle East optimism as Nasdaq drags 1 hr ago

EconPulse

Markets. Economy. Malaysia & The World.

Independent economic news aggregation for Malaysia, Asia and global markets, updated throughout the day.

Company

About Us Editorial Standards & Corrections Privacy Policy

Work With Us

Submit a Press Release Partnerships & Advertising Contact Us RSS Feed

Contact

editor@econpulse.my

Editorial & newsroom enquiries answered within 1–2 business days.

Could Revolution Medicines (RVMD) Become a $20 Billion Cancer Drug Story?

Summary

More in Markets

Block slashed 40% of its workforce for AI — and its earnings suggest that’s paying off

Sandisk’s stock falls as the company’s forecast doesn’t live up to high expectations

Aggressive options trading helped drive the S&P 500’s latest rally. What that means for investors.

Fed Governor Cook says she's 'prepared to act' on rate hike to address inflation

Figma’s push into AI agents drives an earnings beat

How parents can keep saving for retirement during the expensive childcare years